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There are 40 000 Malaysians suffered stroke and stroke become the third major killer in 
Malaysia. Stroke happens when the blood supply which carries vital oxygen and nutrients are 
disrupted by the blood vessel wall ruptures or get clogged. The Gillian Pearce Mechanical 
Thrombectomy Device (GP MTD) is the device that can remove the blood clot with the concept 
of suction. However, the pressure must not cause the damage to the blood vessel. Computational 
Fluid Dynamic (CFD) will be used to simulate the flow in GP MTD. The movement of clot in 
blood is predicted using Navier Stokes Equation where two immiscible phases is considered. In 
the project, three geometry ofGP Device has been designed with the different number of helical 
spiral which are zero, five and ten helical spiral. The suction pressure is varied to three 
conditions which are 40kPa, 50kPa, and 60kpa. Suction rate will increase when the suction 
pressure in increased. Suction rate also increase when less spiral is used but the pressure drop 
during the suction will increase. Lower pressure drop is desirable for the blood clot removal 
process to avoid artery rupture. 
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1.1 BACKGROUND STUDY (STROKE) 
Stroke is a third major killer in Malaysia after heart diseases and cancer (NASAM, 
2010). There are 40 000 people suffur strokes each year including children but the huge 
quantity of the cases affect adult. Stroke becomes the single most common cause of 
severe disability. The figure below is the percentage of factors that cause the stroke for 
low-mortality developing countries including Malaysia. (WHO, 2011) 
high blood pressure 
tobacco use 
low fruit Et vegetable intake 
10% underweight 
6 % indoor smoke from solid fuels 
6 % iron deficiency 
6·% unsafe water, sanitation &: hygiene 
major risk factors 
other risk factors 
Low-mortality developing countries 
Figure 1.1 : Percentage ofFactors That Cause Stroke For Low-Mortality Developing 
Countries 
Stroke will attack brain and occurs when the supply of blood that containing oxygen and 
nutrients to the brain is disrupted. The brain is the main nerve center of the body. In 
order to continuously working, the brain needs constant vital oxygen and nutrients from 
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Figure 1.2: Cause of Stroke; Blood of supply to the brain is disrupted. 
Strokes may be divided into two essential types (EverydayHeahh, 1999). First, there is 
Ischemic stroke. This type of stroke initiated when blood supply is interrupted. The 
interruption is caused by existence of blood clots in the artery. The blood clots will block 
the blood flow resulting in the stuck in the artery. The second is known as Hemorrhagic 
Stroke. It occurs when bleed or hemorrhage caused by the burst of a blood vessel in or 
around brain. Hemorrhagic happens because high blood pressure that left untreated gives 
a strain on the artery walls and finally increases the risk of bursting and bleeding. Artery 
burst resuhs in the blood is forced into the brain tissue and will damage the cells and 
fmally the brain malfunctions 
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Figure 1.3 :The Types of Stroke: Ischemic Stroke and Hemorraghic Stroke 
The treatments for stroke are divided to three categories (Pearce, 2009). First are 
thrombolytic like tissue plasminogen activator (tPA). The research by National Institute 
of Neurological Disorder and Stroke shows that the rate of death and disability was 
reduced if the recombinant (rt) -tPa was admistered within 3 hours onset of the 
symptom. Rt-rPa is still the most popular and well-known thrombolytic agent today. 
However, it cannot be used in patients who have undergone recent surgery, and it may 
cause bleeding at the site of the clot in some instances. In fact that it is only licensed fur 
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Figure 1.4 :Treatment for Stroke; thrombolytic. Example :tissue plasminogen activator 
(tPA). 
Second are the mechanical thrombectomy devices (MTD). The recently invented and 
patented "GP" MTD (Pearce, et al., ,2008) is a clot removal device uses the concept of 
suction, through a micro catheter, allows removal of thrombus even though without 
direct contact with the clot surface. The design of the device has a helical design, with 
the sectional force applied and less of moving parts. It will produce a vortex at the 
catheter tip to remove the blood clot. 
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Figure 1.5 : Treatment for stroke : Mechanical Thrombectomy Device 
Third, are neuroprotective agents however, none of the latter is yet licensed for use in 
human beings. 
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1.2 PROBLEM STATEMENT 
Computational Fluid Dynamic (CFD) contributes a lot to build a computational model 
that represent GP device. The physics and chemistry of the flood flow can be applied to 
this virtual prototype. It will be the output a prediction of the fluid dynamic and related 
physical phenomena. Similarly, the blood clot phenomena in the artery can be stimulated 
using CFD technology (Pearce, et al 2009). Instrumentation for designing GP device is 
extremely difficult as the flow measurement of the device is small and the operating 
conditions severe. Therefore it became essential to look at the flow by the computational 
methods. 
Mechanical thrombectomy device (MTB), the second method for stroke treatment will be 
focused in this project. The recently invented and patented "GP" MTD (Pearce, et al., 
,2008) will be specialized in this project. 
Pressure and time taken for the device to gently remove the clot safely without damaging 
the artery wall need to be determined. In existing design, helical spiral will be able to 
gradually remove the clot and the pressure is gradually increased (Pearce, et al, 2009). 
The vortex generated eases the suction action. 
Double lumen 
chateter tube 
of de• ice 
GPMTO 
attached to 




Figure I. 6 : The illustration of GP MTD 
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1.3 OBJECTIVES 
The objectives of this project are : 
• To determine the suction pressure and time taken to remove the blood clot 
• To investigate the pressure distribution during suction. 
• To characterize the velocity around the clot. 
1.4 SCOPE OF STUDY 
CFD Techniques have been recognized as an alternative specific experimental 
investigation and traditional mathematic modeling. Simulation of blood clot in an artery 
at laminar flow on the modern medical device like GP model is necessary and important 




Blood contain blood cells, platelets, mineral ions, protein glucose, oxygen and carbon 
dioxide which those are the nutrient and wasted to be transported. 40 % of the blood 
volume is the red blood cells. Because blood is a complex mixture, the blood does not 
show a constant viscosity at all flow rates compared to water. The blood is non-
Newtonian in the microcirculary system in small branches or capillaries and the normal 
blood flow is laminar with secondary flows generated at curved or branches. The blood 
flow and pressure is unsteady because the pulsating conditions in all arteries created by 
the heart. The Reynolds number for the blood varies from I in small arterioles to 
approximately 4000 in largest artery. (Xu et al.,2008) 
The objective of thrombolytic treatment is to dissolve blood clots at the same time 
reestablish the normal vessel functions. Serza(2005) said that the experimental resuhs by 
Skharov and Rijken present that the fast blood plasma flow significantly improves blood 
flow dissolution under optimal biochemical dissolution. However, there is no a reliable 
theoretical model presented yet. The hypothesis shows that mechanical forces of flowing 
blood are strong enough to play the function in dissolution of blood clots in addition to 
the biochemical reactions that responsible for chemically degrading the clot. The forces 
from mechanical work can cause the strain deformations and surfuce vibrations, and 
fuster chemically degrade it. When the blood is slow-laminar mechanical forces have a 
viscous origin and when blood is fust-turbulent mechanical forces have a kinematic 
origin. 
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During the dissolution process, the volume flow of the blood through the vessel is 
assumed to be constant. However, at the starting point of the dissolution process, the 
assumption may not be exactly correct because the blood clot will strongly obstruct blood 
movement and may pose the higher resistance to blood flow than other vessels. The 
assumption will simplizy the model and the value will not really different from the real 





Figure 2.1 :Forces of the flowing blood to the surface of the clot in tbe flow channel are 
s) viscous when flow is slow-laminar b) become kinematic 
The GP MTD can be manufactured with two device positioning. First is by mounted on 
the catheter and second is by embedded within the chatterer. From the research ( Pearce 
et al,(2006)) when accessing clot extraction time, there is almost no difference was 
observe between the device position. However, respect to fluid removal, the embedded 
device bring more effective and there are big differences observed between mounted 
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Figure 2.2: Volume of fluid removed vs mass of blood clot for fluid flow rate of 10.6 
ml/sec through the end mounted and embedded GP Device. 
The effectiveness of GP MTD Device is based on the range of clot masses and size. For 
example, the 2.0-mm GP MTD Device is effective to remove a large clot in a porcine 
abattoir artery. There appears to be a relationship between clot removal times and clot 
length in the plastic tube and generalized relationship between the amount of the time for 
which the clot was resident in the tube respect to clot removal time (Pearce et .a!, 2009) 
Abattoir porcine artery 
'GP' MTD mounted on 
end of arterial catheter 
Abattoir Porcine 
blood clot 
Figure 2.3 : Removal of 5-cm blood clot from abattoir artery using GP MTD 2.5 mm in 
diameter 
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The removal time of blood clot for GP MTD is related with the clot length in the plastic tube, 
and generalized relationship between the amounts of the for which the clot was residence in the 
tube with the respect to clot removal times. However, these results are only for plastics tubes 
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Figure 2.4 : Time for which clot resident in tube versus time taken to remove clot 





The project uses the ANSYS fluids dynamics solution to find the result of simulation as it 
can gain the trust result. A wide-ranging suite of advanced CFD modeling capabilities 
will be provided by ANSYS fluids dynamic technology, including advanced models for 
multiphase such as free surface, boiling, wet steam, slurries, real gas, noise, solidification 
and mehing. 
ANSYS fluids dynamics solutions are fully integrated into the ANSYS Workbench 
Platform. All the project workflows starting from pre-processing until the post processing 
already integrated in ANSYS Workbench Platform. The optimization and exploration of 
the design can be done are easily by using this platform. The Multiphysics requirements 
like fluid structure interaction studies, electromagnetic or fluid coupling also provided in 
this platform. 
To represent the design, the simulation will start with geometry. This geometry can be 
designed in a computer-aided design (CAD) system or constructed from scratch. ANSYS 
DesignModeler software is the entrance to geometry handling for analysis with software 
from ANSYS. By using ANSYS DesignModeler, the parameters of the design can then 
be modified and the design updated, and any feature removal or simplification is 
maintained. 
The most difficult part of engineering simulation is mesh generation. Too many cells will 
result in long solver runs, and too few cells will lead to inaccurate results. ANSYS 
Meshing technology provides a way to balance these needs and produce the right mesh 
for each simulation in the most automated way possible. ANSYS Meshing technology 
has been built on the strengths of stand-alone, class-leading meshing tools. The strongest 
aspects of these separate tools have been brought together in a single environment to 
produce some of the most powerful meshing available. 
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ANSYS Fluent software provides us wide physical modeling capabilities required in 
model flow, turbulence, heat transfer and also reactions for industrial application such as 
air flow over aircraft wing, combustion in furnace, semiconductor manufacturing and 
also blood flow. Advanced solver technology results in fast and accurate CFD results. By 
using ANSYS capable, user can easily manage the solver setup, do the calculation, 
examine the results, changing any setting and analyze the results. 
PRE 
PROCESSING 





• Specify operating 
condition, boundary 
condition, material 
• Adapting the regicm 
of blootclot 
• Run the simulation 
Figure 3.1 : Basic steps in CFD 
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3.2 PRE-PROCESSING 
Before starting the simulation, the first step is to design the geometry by using the 
ANSYS DesignModeler software. The geometry must he draw in 3- dimensional since 
the deformation of the blood clot need to he observed during simulation process. All the 
tools in DesignModuler such as draw, sweep, extrude and dimension need to he handling 
wisely to design the desired geometry. 
The design is developed based on the artery and the GP Device. For this project, the 
diameter of the artery is 3mm. The GP Device diameter is 1 mm and the length of the GP 
Device is about 20 mm. The GP Device contains a helical spiral with 12 mm length of its 
central axis. The catheter which contains the helical spiral is positioned with 3mm of the 
blood clot that is occluding the artery by 100%, so no blood is flowing out the artery. 
Below is the image of the geometry. 
' t 
~X 
Figure 3.2 :The geometry ofthe artery and GP Device (no spiral) 
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Figure 3.4 : The geometry of the artery and GP Device ( 10 spiral) 
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Once the geometry already drawn by DesignModuler, it can be load to ANSYS Meshing 
to generate the mesh. CFD will be the physics preference for the mesh and Fluent will be 
the solver. Six meshing methods are available for 3D geometries in ANSYS Meshing. 
There are Tetrahedron, Sweep, Multizone, Hex Dominant, CutCell mesh and Automatic. 
Pressure inlet, pressure outlet and wall are three identical faces presents in the mesh and 
all of them need to be set in Named Selection of the model. The quality of the mesh need 
to be checked up to avoid inaccurate resuhs. The minimum value for orthogonal quality 
is important and should not fall below 0.05. The minimum for this mesh is acceptable. 
3.3 RUNNING/SOLVING 
Once the geometry is designed and the mesh already generated, running and solving 
processes of simulation will take place. During this step, the boundary condition, material 
and operating condition are specified based on the case of the simulation. 
The main objective of this simulation was on study the behavior of blood clot when the 
number of helical spiral tum is different. The blood clot must be removed safely. 
Therefore, the solver to be used in the simulation is the solver for laminar, incompressible 
and unsteady-state flow ofNewtonian fluid. 
In the project, ANSYS Fluent is used to perform the simulation. The type of solver is 
Pressure-Based type. The velocity formulation of the solver is Absolute type and the time 
is Steady type. The formulation type operated is Implicit. I" order Implicit Unsteady 
State is used since the operating fluid is blood and its flow is intermittent due to heart 
pumping. 
The main project of the project is Multiphase model and the primary model is Volume Of 
Fluid. The scheme of the volume fraction parameters is Explicit. The courant number is 
set up to 0.25 and tbe number of Eulerian Phase is two, which is blood and blood clot. 
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There are two material used in the simulation which are blood clot and blood. The phase 
for both materials is fluid but the blood clot will is assumed to be gel-like phase. The 
blood clot is located at the inlet of GP Device. The properties of blood and blood clot are 
determined in the software. The density and viscosity for both materials are stated below. 
Properties Blood Blood Clot 
Density ( kg/m3) 1060 1080 
Viscosity ( kg/s) 0.0035 0.05 
Table 3.2: The properties of blood and blood clot 
Then, the two phases are defmed. Blood is the primary phase and the blood clot is the 
secondary phase. Other parameter such as wall adhesion, shear stress and surfuce tension 
can be applied during the simulation. Next, the operating condition such as pressure 
inside the vessel and its reference location is set based on the findings. 
Now, the blood clot in the blood vessel needs to be specified. The process can be done by 
adapting the region for this blood clot. Once, the blood clot emerges, it is patched inside 
the blood vessel resulting in two different phases. Below is the image ofthe region of the 
blood clot 
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Figure 3.3 :The region of the blood clot 
After all the parameters of simulation have been set up, the simulation is ready to be 
solved. Some input need to be inserted in the solver setting. The setting are below 
Equation Flow, Volume Fraction 
Pressure-velocity coupling PISO 
Pressure PRESTO! 
Momentum QUICK 
Volume Fraction First Order Upwind 
Table 3.2: The solver parameters setting for the simulation. 
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3.4 POST PROCESSING 
Once the model is iterated and solved based on desired parameters, the results of the 
simulation can be observed quantitatively. Contours, vectors and line/rake pathlines are 
among the general method that usually used during the post processing steps. 
The post-processing step is the most important step in the entire simulation. At this step, 
blood deformation in the blood vessel can be studied by observing the movement of 
blood clot when the pressure is applied to it. It can be done by help of moving frames or 
animation properties in ANSYS Fluent. When the calculation or solving process is 
fmished, the software will create the date file (.dat) at each time step that has been set up. 
The data files are used as a frame and need to combine with other frames to create the 
animation sequence. Once the animation sequence is prepared, Fluent will convert it to 
media format known as .mpeg. 
19 
CHAPTER4 
RESULT AND DISCUSSION 
4.1 RESULT 
In this project, the objective is to observe the blood clot deformation and it behavior 
when the different number of helical spiral used at the certain pressure applied. Then, the 
media file containing sequence of frames is saved. Table 4.1-4.9 shows the sequence of 
blood deformation in the GP Device at certain time when a pressure of 40kPa,50kPa and 
60kPa are applied at the outlet of the device, respectively. 
We will notice that the blood start to deform as soon as the pressure applied at the outlet 
of the device. It was shown when using the minimum pressure of 40kPa; the blood clot 
still can be sucked. 
20 
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Table 4.2: Image of blood clot in the zero helical spiral device at time, t with suction pressure, ~p = 50kpa 
0.00 s O.oi s 0.02 s 0.03 s 
~/ ./ • 
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Table 4.3: Image of blood clot in the zero helical spiral device at time, t with suction pressure, t.P = 60kpa 
0.00 s O.oi s 0.02 s 0.03 s 
. / ·"' • 
] ~r~ --~0.0~4s----~r---~0.05~s---+l--~0~.06-s---+l--~~~~~~~ 
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Table 4.5: Image of blood clot in the 5 helical spiral device at time, t with suction pressure, 11P = 50kpa 
0.00 s 0.01 s 0.02 s O.o3 s 
!§ 
~ I 0.04 s I 0.05s I 0.06 s I O.o7 s I 
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Table 4.6: Image of blood clot in the 5 helical spiral device at time, t with suction pressure, L\P = 60kpa 
0.00 s O.ot s 0.02 s O.Q3 s 
"§ 
! 1 0.04 s _ 1 0.05s 
4 
1 0.06 s 1 0.07 s 1 
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Table 4.7: Image of blood clot in the 10 helical spiral device at time, t with suction pressure, ~p = 40kpa 
s s s 
I 0.07 s 1 • I '"' / ·a I o.os, , e I '·"'' - -
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Table 4.8: Image ofblood clot in the 10 helical spiral device at time, t with suction pressure, ~p = 50kpa 
s s s s 
] 




Table 4.9: Image of blood clot in the lO helical spiral device at time, t with suction pressure, L'lP = 60kpa 
0.00 s 0.01 s 0.02 s 0,03 s 
] 
~ I o.o4 s I o.oss I o.o6 s I oms I 
-
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Figure 4.1: Time taken to remove the blood clod versus the suction pressure ofGP Device 
( zero spiral) 
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Figure 4.2: Time taken to remove the blood clod versus the suction pressure of GP Device 
( 5 spiral) 
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Figure 4.3: Time taken to remove the blood clod versus the suction pressure ofGP Device 
( I 0 spiral) 
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From the Figure 4.1, 4.2 and 4.3, the deformation rate of the blood clot is greater when 
higher pressure is applied at the end of the catheter. GP Device with different number of 
helical spiral will completely remove the blood in the filstest when using the highest 
pressure. The deformation rate is highest when using the pressure of 60 kPa , following 
by 50kPa and 40kPa. 
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Although the blood clot can be sucked out with the less of time with the higher force but 
this is true that the higher pressure tend to suck out with the greatest force. The greater 
force tends to cause an injury to the blood vessel. So for this project, GP Device with the 
suction pressure of 40kPa to be applied in the real situation as it can avoid the risk of 
blood ruptures during the treatment. 
From the previous discussion, the GP Device with the suction pressure of 40kP A is 
preferable to be used in the treatment. From the table 4.1-4.9, it shows that the GP Device 
with no helical spiral can completely sucked out the blood clot very fast following by the 
GP device with the 5 and 10 helical spiral. Although the blood clot can be sucked out 
very fust without using the helical spira~ but the spirals will provide the safe precaution 
measurement to suck the blood safely. 
Table 4.6, 4.6 and 4.7 shows the maximum pressure founded during the frrst 0.01 second 























Figure 4.4 :The maximum pressure founded in the artery at the end of the GP Device 























Figure 4.5 :The maximum pressure founded in the artery at the end of the GP Device 






















Figure 4.6 : The maximum pressure founded in the artery at the end of the GP Device 
( 10 Spiral) for frrst O.Ols removal process. 
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From the maximum pressure founded in the artery at the end of the GP Device, the 
maximum pressure drop in the artery during the first 0.01s of the suction process can be 
determined. The maximum pressure drop is the different pressure between the normal 
pressure in the artery and the maximum pressure founded during the suction process in 
the artery. Lower pressure drop is desirable for the blood clot removal process to avoid 
artery rupture. From the Figure 4.7, the 10 spiral ofGP Device is desirable for the blood 
clot removal process. 
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140 _!. _____________ ---------- ------------------------------
120 +------- ---- ---
100 -:----------------
Maximun 
Pressure Drop 80 +------------------- ---
(Pa) 
60 
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20 
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Figure 4.7: The maximum pressure drop rounded in the artery at the end of the GP Device 
for frrst 0.01s removal process. 
Besides that, the spirals of the device will create the sort of vortex that will assist to 
decrease the pressure drop during the suction process. From the Table 4.8-4.9 , the 
velocity vectors of the fluid inside the vessel will moves in the helical form. There is no 
helical movement observe in for GP Device with no helical spiral. But the helical 
movement or the vortex are easily be observed for device with five and 10 spirals. When 
the number ofhelical is increase, the vortex created also increased. 
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Figure 4.8: Image ofBlood Clot Velocity in the Zero Helical Spiral Device at Time, t with 
suction pressure, P = 40kPa 
Figure 4.9: Image ofBlood Clot Velocity in the 5 Helical Spiral Device at Time, t with suction 
pressure, P = 40kPa 
Figure 4.10: Image of Blood Clot Velocity in the 10 Helical Spiral Device at Time, t with suction 
pressure, P = 40kPa 
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CHAPTER4 
CONCLUSION AND RECOMMENDATION 
4.1 CONCLUSION 
In order to predict the blood clot removal from blood artery, we need to study on 
hydrodynamic behavior when designing blood clot removal system .The project will 
evaluate the suction pressure and also the time taken to extract it. The effects of the 
number ofhelical spiral on the suction rate also need to be examined. 
All the objectives of this project are achieved. The conclusions are: 
• The suction pressure and time taken to remove the blood clot has been 
determined. When the suction pressure is increased, suction rate for clot removal 
will increase. 
• Suction rate also increase when less spiral is used but the pressure drop during the 
suction will increase. 
• Lower pressure drop is desirable for the blood clot removal process to avoid 
artery rupture. 
• Spirals of the device will create the sort of vortex that will assist to decrease the 
pressure drop during the suction process. When the number of helical is increase, 
the vortex created also increased. 
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4.2 RECOMMENDATION 
The project has to be done in 2 semesters of study only. Therefore, the time for the 
research to be done is quite limited. Therefore, in order to have advancement for this 
project in the future, instead of using VOF model as the selected model in ANSYS 
Fluent, the study can be further enhanced by using different multiphase model to compare 
the accuracy of result. There are few other model such as Discrete Phase Model (DPM), 
Mixture model and Eulerian Multiphase model. 
Besides that, the study also can be done by taking into the consideration about the 
component in blood. In blood, there are other component such as red blood cells, white 
blood cells, platelet and etc. Therefore, the real condition ofblood can be simulated. 
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